Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Monitoring Batch Yield during Injectable Production – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Monitoring Batch Yield during Injectable Production – V 2.0

Standard Operating Procedure for Monitoring Batch Yield during Injectable Production


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/135/2025
Supersedes SOP/SIM/135/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To outline a standardized procedure for monitoring, calculating, documenting, and reviewing batch yield during the manufacturing of sterile injectable products. This ensures production efficiency, identifies losses, and maintains compliance with GMP guidelines.

2. Scope

This SOP applies to all sterile injectable

product batches manufactured at the facility, including vials, ampoules, and prefilled syringes, from solution preparation to final yield reconciliation.

3. Responsibilities

  • Production Executive: Records real-time yield data and identifies deviations.
  • Quality Assurance (QA): Reviews and approves yield records and investigates deviations.
  • Manufacturing Supervisor: Oversees yield performance and signs off final batch reconciliation.
See also  Sterile Injectable Manufacturing: SOP for Validation of Cleaning Processes for Sterile Equipment - V 2.0

4. Accountability

The Head of Manufacturing is accountable for ensuring implementation and compliance with yield monitoring procedures.

5. Procedure

5.1 Yield Types and Definitions

  • Theoretical Yield: The expected quantity of product based on input raw materials.
  • Actual Yield: The measured output after manufacturing.
  • Percentage Yield: (Actual Yield / Theoretical Yield) × 100

5.2 Monitoring at Each Manufacturing Stage

  1. Solution Preparation:
    • Record volume of prepared solution.
    • Note all losses due to sampling, testing, or equipment retention.
  2. Filtration:
    • Record volume before and after filtration.
    • Account for losses due to filter hold-up volume.
  3. Filling:
    • Record quantity of filled units.
    • Note volume per unit, overfills, and underfills.
    • Calculate yield after filling.

5.3 Yield Calculation Steps

  1. Calculate theoretical yield based on the batch size (e.g., 100 L = 100,000 mL = 100,000 ampoules @ 1 mL).
  2. Record actual quantity obtained after filling and sealing.
  3. Calculate % yield:
    % Yield = (Actual Units / Theoretical Units) × 100

5.4 Documentation and Review

  1. Enter details in the Batch Yield Logbook (Annexure-1).
  2. Attach filled yield calculation sheet to the Batch Manufacturing Record (BMR).
  3. QA to review yield and approve or initiate deviation if outside limits.
See also  Sterile Injectable Manufacturing: SOP for Osmolality Testing of Injectable Products - V 2.0

5.5 Yield Deviation Investigation

  1. If yield is <95% or >105%, treat it as a deviation.
  2. Production must fill a Deviation Report (Annexure-2).
  3. QA to conduct a root cause investigation and implement CAPA if necessary.

5.6 Corrective and Preventive Actions

  • Corrective action may involve process modification or retraining.
  • Preventive action may include additional checks at filtration or filling.

5.7 Yield Trending

  1. QA to maintain monthly yield trend charts by product type.
  2. Report consistent losses for further process optimization.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • BMR: Batch Manufacturing Record

7. Documents

  1. Batch Yield Logbook – Annexure-1
  2. Deviation Report – Annexure-2
  3. Yield Calculation Sheet – Annexure-3

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • WHO GMP Guidelines – Manufacturing Controls
  • 21 CFR Part 211 – Subpart F – Production and Process Controls

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Batch Yield Logbook

Date Batch No. Theoretical Yield Actual Yield % Yield Remarks
21/06/2025 INJ/2025/045 100,000 98,500 98.5% Within Limit

Annexure-2: Deviation Report

Report No. DEV/135/2025/01
Date 22/06/2025
Batch No. INJ/2025/048
Observed Yield 92.8%
Investigation Summary Spillage observed during filling
Corrective Action Operator retraining
Preventive Action Additional filling line supervision

Annexure-3: Yield Calculation Sheet

Batch No. INJ/2025/045
Total Volume Prepared 100 L
Volume per Unit 1 mL
Theoretical Units 100,000
Actual Units 98,500
% Yield 98.5%

Revision History

Revision Date Revision No. Details Reason Approved By
01/06/2022 1.0 Initial release New SOP QA Head
24/06/2025 2.0 Expanded to include trends and deviation reporting Annual Review QA Head
See also  Sterile Injectable Manufacturing: SOP for Documentation of In-Process Control Activities - V 2.0
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: How to Conduct a Risk-Based Evaluation Before SOP Implementation
Next Post: Elixir Department: SOP for Pressure Relief Valve Operation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version